Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
4(17%)
Results Posted
18%(2 trials)
Terminated
1(4%)

Phase Distribution

Ph not_applicable
7
29%
Ph phase_2
1
4%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

24

all time

Status Distribution
Active(5)
Completed(11)
Terminated(1)
Other(7)

Detailed Status

Completed11
unknown7
Recruiting4
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
4
Success Rate
91.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

unknown729%
recruiting417%
completed1146%
not_yet_recruiting14%
terminated14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT06996561Phase 2

Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management

Recruiting
NCT04528303Not Applicable

Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty

Recruiting
NCT03887182Not Applicable

Contribution of Functional MRI in Assessment of Auditory Processing Disorders

Completed
NCT03427593Not Applicable

Severe PID With Lymphoproliferation and Neutropenia

Completed
NCT03911531

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

Recruiting
NCT07051213Not Applicable

The Belgian Genome Resource to Resolve Rare Diseases

Completed
NCT04047433Not Applicable

The Occurrence of Single Nucleotide Polymorphism Among Women Who Experienced Obstetric Anal Sphincter Injury

Completed
NCT06803784

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

Recruiting
NCT04384250

Genetic and Immunologic Basis of COVID-19 Infection

Completed
NCT03276637Not Applicable

Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force

Completed
NCT05736237

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen Development

Completed
NCT06244069

Clonal Hematopoiesis in Giant Cell Arteritis

Not Yet Recruiting
NCT06001957

Whole Exome Sequencing in Coronary Artery Ectasia

Completed
NCT03525431Not Applicable

Clinical Utility of Pediatric Whole Exome Sequencing

Completed
NCT03619512

Genomic and Proteomic Study of Richter Syndrome (CGPSR)

Unknown
NCT03857607

Natural History Study of ATP1A3-related Disease

Unknown
NCT03901391

Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa

Completed
NCT04506398

Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Unknown
NCT02964481

Malignant Hyperthermia Registry and Genetic Testing

Terminated
NCT04506229

Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function

Unknown

Drug Details

Intervention Type
GENETIC
Total Trials
24